Press Releases
TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection
November 18, 2024
SUZHOU, China , Nov 18, 2024 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage company dedicated to developing novel therapies to address unmet ne...